Benitec Biopharma (BNTC) Invested Capital: 2019-2025
Historic Invested Capital for Benitec Biopharma (BNTC) over the last 6 years, with Mar 2025 value amounting to $317.7 million.
- Benitec Biopharma's Invested Capital rose 2662.22% to $317.7 million in Q1 2025 from the same period last year, while for Mar 2025 it was $317.7 million, marking a year-over-year increase of 2662.22%. This contributed to the annual value of $47.2 million for FY2024, which is 23290.10% up from last year.
- As of Q1 2025, Benitec Biopharma's Invested Capital stood at $317.7 million, which was up 12.84% from $281.5 million recorded in Q4 2024.
- In the past 5 years, Benitec Biopharma's Invested Capital ranged from a high of $317.7 million in Q1 2025 and a low of $202,000 during Q2 2023.
- Its 3-year average for Invested Capital is $85.0 million, with a median of $22.3 million in 2023.
- Its Invested Capital has fluctuated over the past 5 years, first plummeted by 92.99% in 2023, then surged by 23,290.10% in 2024.
- Quarterly analysis of 5 years shows Benitec Biopharma's Invested Capital stood at $10.8 million in 2021, then dropped by 17.00% to $9.0 million in 2022, then soared by 72.00% to $15.5 million in 2023, then soared by 1,719.64% to $281.5 million in 2024, then spiked by 2,662.22% to $317.7 million in 2025.
- Its Invested Capital was $317.7 million in Q1 2025, compared to $281.5 million in Q4 2024 and $64.2 million in Q3 2024.